hotspot -WSS

hotspot

author：knowledge 2025-09-06 03:30:51 - browse：88

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits.

The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health. Novo is testing Wegovy, a weekly injection also sold under the brand name Ozempic for type 2 diabetes, against placebo in the five-year study.

The implications are massive, and not just for Novo. Wegovy is part of a class of medicines that target a hormone called GLP-1, which curbs patients’ appetites. Those drugs have demonstrated an ability to help people lose dramatic amounts of weight in clinical trials, but payers, including Medicare, have been slow to reimburse for them without definitive data on their long-term health benefits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Medicare drug price negotiation’s day in court

knowledge

WSS

Creating egg and sperm cells from stem cells raises ethical issues

Intermittent fasting comes with a heart risk? Not so fast

FDA drug safety: Singulair case shows systemic surveillance flaws

New Ultima Genomics DNA sequencer can read genome for $100

Argenx readies a blockbuster opportunity with drug for autoimmune disease

What we need to know about Arena Bioworks

focus

hotspot

focus

Hepatitis C has a cure — but many Americans still lack access to it

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Medicare proposal to cover medical devices draws a mixed reaction

FDA drug safety: Singulair case shows systemic surveillance flaws

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Future doctors should be trained to promote social change

Jerome Adams on the need for new antivirals for Covid

New Ultima Genomics DNA sequencer can read genome for $100

Dobbs anniversary: the lost opportunity of abortion as health care

New Ultima Genomics DNA sequencer can read genome for $100

Wikipedia

SAMSHA loosens regulations on methadone treatment centers

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Medicare drug price negotiation’s day in court

Congressmen charge Covid hearing ‘could have been an email’

Future doctors should be trained to promote social change

Wikipedia

knowledge

focus

focus